Company / Working Capital per Share
Kymera Therapeutics, Inc. Working Capital per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$12.14
FY2025
5-year range
$6.66 / $12.14
FY2021-FY2025
Trend
+52.5%
vs FY2024
Sector context
#37 of 210
Health Care
What the data says
Kymera Therapeutics, Inc.'s working capital per share of $12.14 is higher than 82% of companies in the Health Care sector (FY2025). Improved from $6.66 to $12.14 over the past 2 years.
Based on SEC 10-K filings.
12.14 in FY2025 with a 5-year CAGR of -34.3%. Top quartile in the Health Care sector.
Improved from $6.66 to $12.14 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +21.6%
- 5-Year CAGR
- -34.3%
- 10-Year CAGR
- -
Sector benchmark
-89.8% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 52.5% year-over-year.
- Ranks #37 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.14 | +52.5% |
| FY2024 | $7.96 | +19.5% |
| FY2023 | $6.66 | -1.4% |
| FY2022 | $6.75 | -16.3% |
| FY2021 | $8.06 | -91.9% |
| FY2020 | $99.36 | +189.6% |
| FY2019 | $34.31 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 30, 2026